Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
MainStay Balanced B MBNBX
- NAV / 1-Day Return 29.40 / −0.24 %
- Total Assets 449.3 Mil
-
Adj. Expense Ratio
- Expense Ratio 2.080%
- Distribution Fee Level High
- Share Class Type —
- Category Moderate Allocation
- Investment Style Large Value
- Credit Quality / Interest Rate Sensitivity —
- Status Closed
- TTM Yield 1.07%
- Turnover 313%
USD | NAV as of Apr 25, 2024 | 1-Day Return as of Apr 25, 2024, 10:06 PM GMT+0
Morningstar’s Analysis MBNBX
Will MBNBX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings —
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
United States Treasury Notes 4.25% | 6.60 | 29.9 Mil | Government |
United States Treasury Notes 4.125% | 4.40 | 19.9 Mil | Government |
iShares Intermediate Govt/Crdt Bd ETF | 4.18 | 18.9 Mil | — |
United States Treasury Notes 4% | 3.16 | 14.3 Mil | Government |
United States Treasury Notes 4% | 2.29 | 10.4 Mil | Government |
JPMorgan Chase & Co | 2.26 | 10.2 Mil | Financial Services |
Us Dollar | 2.25 | 10.2 Mil | Cash and Equivalents |
Vanguard Russell 1000 Value ETF | 2.05 | 9.3 Mil | — |
Johnson & Johnson | 1.76 | 8.0 Mil | Healthcare |
Merck & Co Inc | 1.68 | 7.6 Mil | Healthcare |